Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Qualifying notice for Tepmetko
- Qualifying notice: Pemazyre
- Qualifying Notice: Retevmo
- Qualifying notice: Truseltiq
- Qualifying notice: Zepzelca
- Qualifying Notice for Gavreto
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Overview
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Applying for a switch
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Additional information
- Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors
- The Prescription Drug List
- Classification of products under the Food and Drugs Act (F&DA)
- Draft Guidance Document - Electronic media in prescription drug labelling
- Electronic media in prescription drug labelling guidance: Legal requirements
- Electronic media in prescription drug labelling guidance: Submission and assessment
- Electronic media in prescription drug labelling guidance: Guidelines
- Draft guidance document profile: Canadian Module 1 Technical Implementation Guide for the Electronic Common Technical Document (eCTD) v4.0 Format
- Explanatory note: Order Respecting Certain Time Limits under the Food and Drug Regulations (COVID-19)
- Guidance Document: Pre-market Requirements for Medical Device Cybersecurity
- Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory
- Health Canada's special access programs: Overview
- Health Canada’s special access programs: Request a veterinary drug through EDR
- Health Canada's special access programs: Request a drug
- Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses
- Notice: Guidance Document - Pre-market Requirements for Medical Device Cybersecurity
- Project Orbis
- 1996 Health Canada Position Statement on Dental Amalgam
- About drugs and rare diseases in Canada
- Access to Drugs in Exceptional Circumstances
- Access to Generic Drugs in Canada
- Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance
- Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management
- Disassemble Encampment FOI #2023-132
- Encampment Dismantle 1 FOI #2023-113
- Waste Collection Areas
- Region of Peel Waste Collection
- A Saint John History
- 2023-11-02 Agenda-Ordre du Jour and MN
- Bridges Feature Layer
- Zoning Map 1995-14864
- Road Interchanges Feature Layer
- Street Signs Feature Layer
- Canadian species index
- Guidance Document - Medical device licence renewal and fees for the right to sell licensed medical devices
- Guidance Document: Management of Applications for Medical Device Licences
- Guidance Document: Software as a Medical Device (SaMD): Definition and Classification
- Notice – Release of ICH M9: Biopharmaceutics Classification System (BCS) Based Biowaivers
- Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility
- Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)
- Notice of Amendment: Prescription Drug List (PDL): Phytocannabinoids